Apr 24, 2014 6:30 am EDT VolitionRx Extends Agreement With University Hospital Bonn to Include CE Mark Performance Evaluation
Mar 17, 2014 8:30 am EDT New VolitionRx Study Data Demonstrates NuQ(R) Assays' High Detection Rate of Prostate Cancer and the Ability to Distinguish Between Prostate and Colorectal Cancer
Jan 22, 2014 6:00 am EST VolitionRx Commences First Large Clinical Trial in Collaboration With Hvidovre Hospital, Denmark
